Investor Presentaiton

Investor Presentation First six months of 2018 Slide 88 Biopharm and other chronic areas LIAM CLEMENS Liam has haemophilia A USA changing diabetes® 1. Biopharm at a glance 89 2. Haemophilia a rare disease 90 3. Haemophilia market 91 4. NovoSevenⓇ 92 5. NovoEight® 6. RefixiaⓇ/RebinynⓇ 7. N8-GP 8. Growth Hormone market 9. Other chronic disease 93 94 95 96 97-99 novo nordisk

View entire presentation